London Health Sciences Centre
‘This will be a huge benefit for society because sepsis is the leading cause of death worldwide’
It’s a discovery that has been more than ten years in the making: the use of a human protein to potentially treat patients with sepsis. Lawson Scientist Dr. Qingping Feng noticed that a human protein called annexin A5 showed positive results with sepsis back in 2007. Fast forward 14 years later to...
Researchers team up with Diagnostics Biochem Canada to study COVID-19
Researchers at Lawson Health Research Institute (Lawson) and Western University have teamed up with local biotech company, Diagnostics Biochem Canada Inc. (DBC), to help us better understand COVID-19 and the body’s immune response to the infection. A recently published study followed 28 critically...
‘This will be a huge benefit for society because sepsis is the leading cause of death worldwide’
It’s a discovery that has been more than ten years in the making: the use of a human protein to potentially treat patients with sepsis. Lawson Scientist Dr. Qingping Feng noticed that a human protein called annexin A5 showed positive results with sepsis back in 2007. Fast forward 14 years later to...
Monitoring the effects of COVID-19 quarantine measures on young adults with mood and anxiety disorders
Concerned that patients from the First Episode Mood and Anxiety Program (FEMAP) at London Health Sciences Centre (LHSC) would lose connection to important mental health services during the first wave of the pandemic, researchers at Lawson Health Research Institute (Lawson) tested the use of an...
COVID-19 shown to leave unique lung fingerprint
Researchers at Lawson Health Research Institute (Lawson) have developed and tested an artificial neural network for diagnosing COVID-19. The AI system was trained to learn and recognize patterns in ultrasound lung scans of patients with confirmed COVID-19 infection at London Health Sciences Centre...
Clinical use of EpiSign proven for diagnosing rare heritable disorders
A study led by researchers at Lawson Health Research Institute (Lawson) provides clinical validation of EpiSign, a molecular genomics test that diagnoses rare, heritable neurodevelopmental conditions. Invented at Lawson by Dr. Bekim Sadikovic, the diagnostic test uses machine learning to analyze the...
Pinpointing the role of language disruptions in psychosis
The ability of humans to use language may also be what puts us at the unique risk of developing psychosis, a subset of mental illness characterized by changes in emotions, impaired functioning, and a disconnection from reality. Difficulties with communication – both the ability to use language and...